Latest in Alzheimers
Sort by
10 items
-
‘We’re living in uncertainty’: My sister has Alzheimer’s disease. How do I know the right time to take control of her finances?
“My eldest sister has asked me to take on her power of attorney for her, and together we met with her attorney.”Business - MarketWatch - 12 hours ago -
Are cancer survivors less likely to develop Alzheimer’s?
Research shows that patients with a history of cancer are less likely to develop dementia and those with Alzheimer’s are less likely to develop cancer. Understanding this relationship, say ...World - The Guardian - November 16 -
Chancellor and BoE governor call for UK to rebuild ties with EU
Reeves and Bailey highlight damage from Brexit amid concern about Trump’s plan to impose tariffs on trading partnersBusiness - Financial Times - November 14 -
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drugHealth - ABC News - November 14 -
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing ...Business - MarketWatch - November 14 -
Britain’s bold plan to create super funds
The case for consolidating the UK’s sprawling pension arsenal is strongBusiness - Financial Times - November 14 -
Alzheimer's researchers say brain stimulation device may slow symptoms
Alzheimer's disease researchers found that when they aimed a TMS device at the right spot in the brain, it could slow the progression of memory loss.Top stories - NBC News - November 1 -
Biogen’s stock hit by soft sales of Alzheimer’s treatment
“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.Business - MarketWatch - October 30 -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - October 30